Annual Accounts Receivable
N/A
31 December 2023
Summary:
Qualigen Therapeutics annual accounts receivable is not available.QLGN Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
N/A
30 September 2024
Summary:
Qualigen Therapeutics quarterly accounts receivable is not available.QLGN Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
QLGN Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
QLGN Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time |
Qualigen Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $679.40 K(+65.3%) |
| Mar 2023 | - | $411.10 K(-31.9%) |
| Sept 2022 | - | $603.30 K(-16.2%) |
| June 2022 | - | $719.90 K(+21.1%) |
| Mar 2022 | - | $594.30 K(-27.7%) |
| Dec 2021 | $822.40 K | $822.40 K(+29.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $633.50 K(-17.4%) |
| June 2021 | - | $766.90 K(-11.1%) |
| Mar 2021 | - | $862.20 K(+133.5%) |
| Dec 2020 | $615.80 K(-12.9%) | - |
| Sept 2020 | - | $369.30 K(+9.4%) |
| June 2020 | - | $337.50 K |
| Mar 2020 | $707.30 K | - |
FAQ
- What is the all time high annual accounts receivable for Qualigen Therapeutics?
- What is the all time high quarterly accounts receivable for Qualigen Therapeutics?
What is the all time high annual accounts receivable for Qualigen Therapeutics?
Qualigen Therapeutics all-time high annual accounts receivable is $822.40 K
What is the all time high quarterly accounts receivable for Qualigen Therapeutics?
Qualigen Therapeutics all-time high quarterly accounts receivable is $862.20 K